Scientific Concerns About Recent Fluid-Structure Interaction Models of the Aqueous Humor Outflow Pathway
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.15.18 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Mark Johnson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States. Hauptthemen laut MEDLINE: Aqueous Humor, Glaucoma, Intraocular Pressure, Models, Biological. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States.
- Department of Bioengineering, Imperial College London, London, United Kingdom.
- Department of Ophthalmology, Duke University, Durham, North Carolina, United States.
- Department of Biomedical Engineering, Georgia Tech/Emory and Department of Ophthalmology, Emory University, Atlanta, Georgia, United States.
Zitieren
APA
Johnson, M., Overby, D. R., Stamer, W. D., & Ethier, C. R. (2025). Scientific Concerns About Recent Fluid-Structure Interaction Models of the Aqueous Humor Outflow Pathway. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.15.18
Vancouver
Johnson M, Overby DR, Stamer WD, Ethier CR. Scientific Concerns About Recent Fluid-Structure Interaction Models of the Aqueous Humor Outflow Pathway. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.15.18
BibTeX
@article{Johnson2025,
author = {Johnson, Mark and Overby, Darryl R and Stamer, W Daniel and Ethier, C Ross},
title = {Scientific Concerns About Recent Fluid-Structure Interaction Models of the Aqueous Humor Outflow Pathway},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.15.18}
}
EUVIMED